A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy
EJ Aspinall, W Mitchell, J Schofield, A Cairns, S Lamond, P Bramley, SE Peters, H Valerio, J Tomnay, DJ Goldberg, PR Mills, ST Barclay, A Fraser, JF Dillon, NK Martin, M Hickman, SJ Hutchinson
Journal of Viral Hepatitis | WILEY-BLACKWELL | Published : 2016
Awarded by National Institute for Drug Abuse
Awarded by University of California San Diego Center for AIDS Research (CFAR), a National Institute of Health (NIH)
Awarded by Medical Research Council
Awarded by National Institute for Health Research
MH acknowledges support from the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Evaluation of Interventions at University of Bristol. NM acknowledges support from the National Institute for Drug Abuse [grant number R01 DA037773-01A1] and University of California San Diego Center for AIDS Research (CFAR), a National Institute of Health (NIH) funded program [grant number P30 AI036214]. The views expressed are those of the authors, and not necessarily those of the UK NHS, the UK NIHR or the UK Department of Health. The authors would like to acknowledge the Clinical Database Monitoring Committee, the Clinical Database data entry staff at the participating NHS Health Boards, and the Scottish Government for funding the Scottish Clinical Database. JD has received honoraria for lectures, advisory panels and support to attend conferences from Janssen, Roche, MSD, Gilead, BMS and Boeringer Ingelheim, and his institution has received grants for research from Janssen, Roche, MSD, Gilead and BMS. SL has been on the nurse advisory board for Abbvie and BMS. DJG has received honoraria for educational contributions (e.g. lectures, reports) and for providing advice on aspects of hepatitis C and public health from Abbvie, Merck, Gilead, BMS, and Janssen. MH has received unrestricted research grants as co-investigator from Gilead and honoraria from Gilead and Janssen. NM has received unrestricted research grants from Gilead unrelated to this work and honoraria from Merck, AbbVie and Janssen. All other authors declare that they have no conflicts of interest in relation to this manuscript.